{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:23:48Z","timestamp":1787790228511,"version":"build-2784847793"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Social Science & Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.socscimed.2026.119565","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:44:32Z","timestamp":1783601072000},"page":"119565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan"],"prefix":"10.1016","volume":"405","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2630-0397","authenticated-orcid":false,"given":"Yeh-Han","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2374-5713","authenticated-orcid":false,"given":"Wen-Hua","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.socscimed.2026.119565_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.socscimed.2014.07.046","article-title":"Understanding the adoption dynamics of medical innovations: affordances of the da Vinci robot in the Netherlands","volume":"117","author":"Abrishami","year":"2014","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2026.119565_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112444","article-title":"Diagnosis: from classification to prediction","volume":"237","author":"Armstrong","year":"2019","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2026.119565_bib3","series-title":"The Social Construction of Technological Systems: New Directions in the Sociology and History of Technology (Anniversary Ed)","year":"2012"},{"key":"10.1016\/j.socscimed.2026.119565_bib4","series-title":"Sorting Things Out: Classification and its Consequences (1. Paperback Ed., 8. Print)","author":"Bowker","year":"1999"},{"issue":"5","key":"10.1016\/j.socscimed.2026.119565_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/0306312709334640","article-title":"Biomedical conventions and regulatory objectivity: a few introductory remarks","volume":"39","author":"Cambrosio","year":"2009","journal-title":"Soc. Stud. Sci."},{"key":"10.1016\/j.socscimed.2026.119565_bib6","series-title":"Evidence-Based Policy: A Practical Guide to Doing It Better","author":"Cartwright","year":"2012"},{"key":"10.1016\/j.socscimed.2026.119565_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.socscimed.2018.04.010","article-title":"Randomized trials and evidence in medicine: a commentary on Deaton and cartwright","volume":"210","author":"Concato","year":"2018","journal-title":"Soc. Sci. Med."},{"issue":"8","key":"10.1016\/j.socscimed.2026.119565_bib8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/hec.3903","article-title":"The impact of pharmaceutical marketing on market access, treatment coverage, pricing, and social welfare","volume":"28","author":"Critchley","year":"2019","journal-title":"Health Econ."},{"issue":"1","key":"10.1016\/j.socscimed.2026.119565_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s40425-019-0768-9","article-title":"The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors","volume":"7","author":"Davis","year":"2019","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.socscimed.2026.119565_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.socscimed.2017.12.005","article-title":"Understanding and misunderstanding randomized controlled trials","volume":"210","author":"Deaton","year":"2018","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2026.119565_bib11","series-title":"Drugs for Life: How Pharmaceutical Companies Define Our Health","author":"Dumit","year":"2012"},{"issue":"1","key":"10.1016\/j.socscimed.2026.119565_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0306312719900545","article-title":"Aligning in the dark: variable and shifting (user-) settings in developing point-of-care diagnostics for tuberculosis and HIV","volume":"50","author":"Engel","year":"2020","journal-title":"Soc. Stud. Sci."},{"issue":"2","key":"10.1016\/j.socscimed.2026.119565_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/reel.12081","article-title":"Chemicals as regulatory objects","volume":"23","author":"Fisher","year":"2014","journal-title":"Review of European, Comparative & International Environmental Law"},{"key":"10.1016\/j.socscimed.2026.119565_bib14","series-title":"Medical Research for Hire: the Political Economy of Pharmaceutical Clinical Trials","author":"Fisher","year":"2009"},{"issue":"3","key":"10.1016\/j.socscimed.2026.119565_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1525\/aa.1994.96.3.02a00100","article-title":"Professional vision","volume":"96","author":"Goodwin","year":"1994","journal-title":"Am. Anthropol."},{"key":"10.1016\/j.socscimed.2026.119565_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.05.023","article-title":"Plastic diagnostics: the remaking of disease and evidence in personalized medicine","volume":"304","author":"Green","year":"2022","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2026.119565_bib17","series-title":"Prescribing by Numbers: Drugs and the Definition of Disease","author":"Greene","year":"2007"},{"issue":"1","key":"10.1016\/j.socscimed.2026.119565_bib18","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1186\/s12885-018-5020-3","article-title":"The 2018 Nobel Prize in medicine goes to cancer immunotherapy","volume":"18","author":"Guo","year":"2018","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.socscimed.2026.119565_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/03063127231154863","article-title":"Reflexive standardization and the resolution of uncertainty in the genomics clinic","volume":"53","author":"Hedgecoe","year":"2023","journal-title":"Soc. Stud. Sci."},{"issue":"2","key":"10.1016\/j.socscimed.2026.119565_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtho.2016.11.2228","article-title":"PD-L1 immunohistochemistry assays for lung cancer: results from phase 1 of the blueprint PD-L1 IHC assay comparison Project","volume":"12","author":"Hirsch","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"21","key":"10.1016\/j.socscimed.2026.119565_bib21","first-page":"6548","article-title":"Real-world results of immune checkpoint inhibitors from the Taiwan National Health Insurance Registration System","volume":"25","author":"Hsieh","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.socscimed.2026.119565_bib22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/diagnostics11030448","article-title":"Interpretation according to clone-specific PD-L1 cutoffs reveals better concordance in muscle-invasive urothelial carcinoma","volume":"11","author":"Huang","year":"2021","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.socscimed.2026.119565_bib23","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1017\/S0266462320002160","article-title":"Lessons learned from the reimbursement policy for immune checkpoint inhibitors and real-world data collection in Taiwan","volume":"37","author":"Huang","year":"2021","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"10.1016\/j.socscimed.2026.119565_bib24","series-title":"States of Knowledge: the co-production of Science and Social Order","author":"Jasanoff","year":"2004"},{"issue":"6","key":"10.1016\/j.socscimed.2026.119565_bib25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.socscimed.2011.07.014","article-title":"Towards a sociology of diagnosis: reflections and opportunities","volume":"73","author":"Jutel","year":"2011","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2026.119565_bib26","series-title":"Biomedical Platforms: Realigning the Normal and the Pathological in late-twentieth-century Medicine","author":"Keating","year":"2003"},{"key":"10.1016\/j.socscimed.2026.119565_bib27","series-title":"Cancer on Trial: Oncology as a New Style of Practice","author":"Keating","year":"2014"},{"issue":"2","key":"10.1016\/j.socscimed.2026.119565_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/1360780420915723","article-title":"Interventional STS: a framework for developing workable technologies","volume":"26","author":"Lyle","year":"2021","journal-title":"Sociol. Res. Online"},{"issue":"4","key":"10.1016\/j.socscimed.2026.119565_bib29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jtho.2022.10.021","article-title":"Expert Consensus recommendations on biomarker testing in metastatic and nonmetastatic NSCLC in Asia","volume":"18","author":"Mitsudomi","year":"2023","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.socscimed.2026.119565_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/0306312709103481","article-title":"Regulatory objectivity in action: mild cognitive impairment and the collective production of uncertainty","volume":"39","author":"Moreira","year":"2009","journal-title":"Soc. Stud. Sci."},{"key":"10.1016\/j.socscimed.2026.119565_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.socscimed.2018.05.003","article-title":"Randomized controlled trials and evidence-based policy: a multidisciplinary dialogue","volume":"210","author":"Mowat","year":"2018","journal-title":"Soc. Sci. Med."},{"issue":"1","key":"10.1016\/j.socscimed.2026.119565_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/soc4.12335","article-title":"Regulating pharmaceutical industry marketing: development, enforcement, and outcome of marketing rules","volume":"10","author":"Mulinari","year":"2016","journal-title":"Sociol. Compass"},{"key":"10.1016\/j.socscimed.2026.119565_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954910","article-title":"Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection","volume":"13","author":"Munari","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.socscimed.2026.119565_bib34","series-title":"Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine","year":"2016"},{"issue":"39","key":"10.1016\/j.socscimed.2026.119565_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1200\/EDBK_237863","article-title":"Biomarker testing for patients with advanced non\u2013small cell lung cancer: Real-World issues and tough choices","author":"Pennell","year":"2019","journal-title":"American Society of Clinical Oncology Educational Book"},{"key":"10.1016\/j.socscimed.2026.119565_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2023.115789","article-title":"Organizing precision medicine: a case study of Memorial Sloan Kettering Cancer Center's engagement in\/with genomics","volume":"324","author":"Polk","year":"2023","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2026.119565_bib38","series-title":"Biocapital: the Constitution of Postgenomic Life","author":"Rajan","year":"2006"},{"key":"10.1016\/j.socscimed.2026.119565_bib39","series-title":"Pharmocracy: Value, Politics, and Knowledge in Global Biomedicine","author":"Rajan","year":"2017"},{"key":"10.1016\/j.socscimed.2026.119565_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.113965","article-title":"Diagnostic layering: patient accounts of breast cancer classification in the molecular era","volume":"278","author":"Ross","year":"2021","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2026.119565_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.socscimed.2018.04.033","article-title":"Randomized clinical trials and personalized medicine: a commentary on deaton and cartwright","volume":"210","author":"Schork","year":"2018","journal-title":"Soc. Sci. Med."},{"issue":"11","key":"10.1016\/j.socscimed.2026.119565_bib42","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1080\/1369118X.2021.1874035","article-title":"Algorithms as regulatory objects","volume":"25","author":"Seyfert","year":"2022","journal-title":"Inf. Commun. Soc."},{"issue":"2","key":"10.1016\/j.socscimed.2026.119565_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0306312704042575","article-title":"Pharmaceutical maneuvers","volume":"34","author":"Sismondo","year":"2004","journal-title":"Soc. Stud. Sci."},{"issue":"2","key":"10.1016\/j.socscimed.2026.119565_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0306312708101047","article-title":"Ghosts in the machine: publication planning in the medical sciences","volume":"39","author":"Sismondo","year":"2009","journal-title":"Soc. Stud. Sci."},{"key":"10.1016\/j.socscimed.2026.119565_bib45","series-title":"Ghost-Managed Medicine: Big Pharma's Invisible Hands","author":"Sismondo","year":"2018"},{"key":"10.1016\/j.socscimed.2026.119565_bib46","author":"Socinski"},{"issue":"3","key":"10.1016\/j.socscimed.2026.119565_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/00027649921955326","article-title":"The ethnography of infrastructure","volume":"43","author":"Star","year":"1999","journal-title":"Am. Behav. Sci."},{"issue":"1","key":"10.1016\/j.socscimed.2026.119565_bib48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1287\/isre.7.1.111","article-title":"Steps toward an ecology of infrastructure: design and access for large information spaces","volume":"7","author":"Star","year":"1996","journal-title":"Inf. Syst. Res."},{"issue":"3","key":"10.1016\/j.socscimed.2026.119565_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2217\/rme-2020-0164","article-title":"Spatiotemporal readiness is key to preparing regenerative medicine for the Clinic","volume":"16","author":"Stephens","year":"2021","journal-title":"Regen. Med."},{"issue":"1","key":"10.1016\/j.socscimed.2026.119565_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/0306312714559323","article-title":"Trust in standards: transitioning clinical exome sequencing from bench to bedside","volume":"45","author":"Timmermans","year":"2015","journal-title":"Soc. Stud. Sci."},{"issue":"1","key":"10.1016\/j.socscimed.2026.119565_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.socscimed.2009.04.020","article-title":"Objectification, standardization, and commodification in health care: a conceptual readjustment","volume":"69","author":"Timmermans","year":"2009","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2026.119565_bib52","series-title":"The Gold Standard: the Challenge of Evidence-based Medicine","author":"Timmermans","year":"2003"},{"issue":"3","key":"10.1016\/j.socscimed.2026.119565_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/1467-9566.00342","article-title":"The practice of medical technology","volume":"25","author":"Timmermans","year":"2003","journal-title":"Sociol. Health Illness"},{"issue":"1","key":"10.1016\/j.socscimed.2026.119565_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.soc.012809.102629","article-title":"A world of standards but not a standard world: toward a sociology of standards and standardization","volume":"36","author":"Timmermans","year":"2010","journal-title":"Annu. Rev. Sociol."},{"issue":"10","key":"10.1016\/j.socscimed.2026.119565_bib55","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.socscimed.2012.07.031","article-title":"Personalizing medicine: futures present and past","volume":"75","author":"Tutton","year":"2012","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2026.119565_bib56","series-title":"Genomics and the Reimagining of Personalized Medicine","author":"Tutton","year":"2016"},{"key":"10.1016\/j.socscimed.2026.119565_bib57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.socscimed.2013.09.008","article-title":"Technology identity: the role of sociotechnical representations in the adoption of medical devices","volume":"98","author":"Ulucanlar","year":"2013","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.socscimed.2026.119565_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1581275","article-title":"Unraveling the complexity of PD-L1 assays: a descriptive review of the methodology, scoring, and practical implications","volume":"15","author":"Vainer","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.socscimed.2026.119565_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2024.116966","article-title":"Infrastructuring precision medicine: making gene therapies for rare diseases workable in practice","volume":"351","author":"Wadmann","year":"2024","journal-title":"Soc. Sci. Med."},{"issue":"10","key":"10.1016\/j.socscimed.2026.119565_bib60","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/09537325.2019.1601694","article-title":"Aligning technology and institutional readiness: the adoption of innovation","volume":"31","author":"Webster","year":"2019","journal-title":"Technol. Anal. Strat. Manag."},{"issue":"3","key":"10.1016\/j.socscimed.2026.119565_bib61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2217\/rme-2021-0034","article-title":"Regenerative readiness: innovation meets sociology","volume":"16","author":"Webster","year":"2021","journal-title":"Regen. Med."},{"issue":"3","key":"10.1016\/j.socscimed.2026.119565_bib62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF03256147","article-title":"Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences","volume":"7","author":"Wettermark","year":"2009","journal-title":"Appl. Health Econ. Health Pol."},{"issue":"1","key":"10.1016\/j.socscimed.2026.119565_bib63","first-page":"121","article-title":"Do artifacts have politics?","volume":"109","author":"Winner","year":"1980","journal-title":"Daedalus"}],"container-title":["Social Science & Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953626006416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953626006416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:06:42Z","timestamp":1787789202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0277953626006416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":62,"alternative-id":["S0277953626006416"],"URL":"https:\/\/doi.org\/10.1016\/j.socscimed.2026.119565","relation":{},"ISSN":["0277-9536"],"issn-type":[{"value":"0277-9536","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Social Science & Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.socscimed.2026.119565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119565"}}